EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Kynurenine Metabolite 3-Hydroxykynurenine is Associated With Risk of Heart Failure in Patients With Predominantly Stable Coronary Artery Disease

Anders Lund, Jan Erik Nordrehaug, Kjell-Christian Flo, Kyrre Hasås Toresen, Christian Alsing, Adrian McCann, Per Magne Ueland, Ottar Nygård, Lasse M Giil iD

International Journal of Tryptophan Research · 2026-08 · 19

DOI: 10.1177/11786469261479281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Tryptophan Research, online erschienen am 18.08.2026. Verfasst von Anders Lund und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Haukeland University Hospital, Bergen, Norway. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helse Vest.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammation and immune activation contribute to the development and progression of heart failure (HF). The kynurenine pathway, linking tryptophan metabolism to inflammation, oxidative stress, and cell death by way of its metabolites (kynurenines), has not been studied as a pathway associated with risk for incident HF.

Aims

To investigate whether kynurenine metabolites are associated with incident HF in patients with predominantly stable coronary artery disease.

Methods

Serum kynurenine metabolites were quantified in 3841 patients who underwent elective coronary angiography for evaluation of chest pain. Fasting was not routine. Patients with established HF at baseline were excluded. The hazard for incident HF was estimated using Cox regression, adjusted for age, gender, current smoking, diabetes, hypertension, previous myocardial infarction, body mass index, glomerular filtration rate, troponin T, left ventricular ejection fraction, and resting heart rate.

Results

During follow-up, 221 participants developed HF. Higher serum concentrations of 3-hydroxykynurenine (HK) were associated with increased HF risk (adjusted HR 1.31, 95% CI 1.07-1.46, P < .001).

Conclusion

Higher plasma HK was independently associated with incident HF in patients with predominantly stable coronary artery disease. These findings support a possible link between kynurenine pathway activity and future HF risk, but the underlying mechanisms and clinical implications remain to be established.

Schlagwörter

Stichwörter der Autor:innen

3-hydroxykynurenineheart failurehydroxykynurenineincidencekynurenine pathway

Autor:innen und Institutionen

  • Department of Anesthesiology, Haukeland University Hospital, Bergen, Norway.
  • Department of Clinical Sciences, University of Bergen, Norway.
  • Voss Hospital, Haukeland University Hospital, Bergen, Norway.
  • Department of Internal Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway.
  • Bevital AS, Bergen, Norway.
  • Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.

ORCID-Profile: Lasse M Giil

Förderung

  • Helse Vest

Zitieren

APA

Lund, A., Nordrehaug, J. E., Flo, K. C., Toresen, K. H., Alsing, C., McCann, A., Ueland, P. M., Nygård, O., & Giil, L. M. (2026). The Kynurenine Metabolite 3-Hydroxykynurenine is Associated With Risk of Heart Failure in Patients With Predominantly Stable Coronary Artery Disease. International Journal of Tryptophan Research, 19. https://doi.org/10.1177/11786469261479281

Vancouver

Lund A, Nordrehaug JE, Flo KC, Toresen KH, Alsing C, McCann A, et al. The Kynurenine Metabolite 3-Hydroxykynurenine is Associated With Risk of Heart Failure in Patients With Predominantly Stable Coronary Artery Disease. International Journal of Tryptophan Research. 2026;19. doi:10.1177/11786469261479281

BibTeX
@article{Lund2026,
  author = {Lund, Anders and Nordrehaug, Jan Erik and Flo, Kjell-Christian and Toresen, Kyrre Hasås and Alsing, Christian and McCann, Adrian and Ueland, Per Magne and Nygård, Ottar and Giil, Lasse M},
  title = {The Kynurenine Metabolite 3-Hydroxykynurenine is Associated With Risk of Heart Failure in Patients With Predominantly Stable Coronary Artery Disease},
  journal = {International Journal of Tryptophan Research},
  year = {2026},
  volume = {19},
  doi = {10.1177/11786469261479281}
}
Kostenlos starten →